| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |